Cargando…
The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis
BACKGROUND: Cutaneous lichen amyloidosis (CLA) has been reported in some multiple endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations C634F/G/R/W/Y or V804M, as a characteristic of the clinical manifestation in ‘MEN 2A with CLA’, one of four variants of MEN 2A,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176283/ https://www.ncbi.nlm.nih.gov/pubmed/30300539 http://dx.doi.org/10.1530/EC-18-0220 |
_version_ | 1783361669706022912 |
---|---|
author | Qi, Xiao-Ping Peng, Jian-Zhong Yang, Xiao-Wei Cao, Zhi-Lie Yu, Xiu-Hua Fang, Xu-Dong Zhang, Da-Hong Zhao, Jian-Qiang |
author_facet | Qi, Xiao-Ping Peng, Jian-Zhong Yang, Xiao-Wei Cao, Zhi-Lie Yu, Xiu-Hua Fang, Xu-Dong Zhang, Da-Hong Zhao, Jian-Qiang |
author_sort | Qi, Xiao-Ping |
collection | PubMed |
description | BACKGROUND: Cutaneous lichen amyloidosis (CLA) has been reported in some multiple endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations C634F/G/R/W/Y or V804M, as a characteristic of the clinical manifestation in ‘MEN 2A with CLA’, one of four variants of MEN 2A, which was strictly located in the scapular region of the upper back. PATIENT FINDINGS: This study reports a large south-eastern Chinese pedigree with 17 individuals carrying the MEN 2A-harboring germline C611Y (c.1832G>A) RET mutation by Sanger sequencing. One individual presented MEN 2A-related clinical features, including typical CLA in the interscapular region; another individual exhibited neurological pruritus and scratching in the upper back but lacked CLA skin lesions. Both subjects presented with CLA or pruritic symptoms several years before the onset of medullary thyroid carcinoma (MTC) and/or pheochromocytoma. The remaining 15 RET mutation carriers did not exhibit CLA; of these, one presented with MTC and pheochromocytoma, nine with MTC only, two with elevated serum calcitonin and three younger subjects with normal serum calcitonin levels. This family’s clinical data revealed a later diagnosis of MTC (mean age, 45.9 (range: 23–73) years), a lower penetrance of pheochromocytoma (2/17, 11.8%) and CLA (1/17, 5.9%). However, no hyperparathyroidism and Hirschsprung disease were reported in this family. SUMMARY AND CONCLUSIONS: This is the first description of a family with MEN 2A-related CLA due to a germline RET C611Y mutation, which might exhibit a novel and diversified genotype–phenotype spectrum in MEN 2A. |
format | Online Article Text |
id | pubmed-6176283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61762832018-10-09 The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis Qi, Xiao-Ping Peng, Jian-Zhong Yang, Xiao-Wei Cao, Zhi-Lie Yu, Xiu-Hua Fang, Xu-Dong Zhang, Da-Hong Zhao, Jian-Qiang Endocr Connect Research BACKGROUND: Cutaneous lichen amyloidosis (CLA) has been reported in some multiple endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations C634F/G/R/W/Y or V804M, as a characteristic of the clinical manifestation in ‘MEN 2A with CLA’, one of four variants of MEN 2A, which was strictly located in the scapular region of the upper back. PATIENT FINDINGS: This study reports a large south-eastern Chinese pedigree with 17 individuals carrying the MEN 2A-harboring germline C611Y (c.1832G>A) RET mutation by Sanger sequencing. One individual presented MEN 2A-related clinical features, including typical CLA in the interscapular region; another individual exhibited neurological pruritus and scratching in the upper back but lacked CLA skin lesions. Both subjects presented with CLA or pruritic symptoms several years before the onset of medullary thyroid carcinoma (MTC) and/or pheochromocytoma. The remaining 15 RET mutation carriers did not exhibit CLA; of these, one presented with MTC and pheochromocytoma, nine with MTC only, two with elevated serum calcitonin and three younger subjects with normal serum calcitonin levels. This family’s clinical data revealed a later diagnosis of MTC (mean age, 45.9 (range: 23–73) years), a lower penetrance of pheochromocytoma (2/17, 11.8%) and CLA (1/17, 5.9%). However, no hyperparathyroidism and Hirschsprung disease were reported in this family. SUMMARY AND CONCLUSIONS: This is the first description of a family with MEN 2A-related CLA due to a germline RET C611Y mutation, which might exhibit a novel and diversified genotype–phenotype spectrum in MEN 2A. Bioscientifica Ltd 2018-07-24 /pmc/articles/PMC6176283/ /pubmed/30300539 http://dx.doi.org/10.1530/EC-18-0220 Text en © 2018 The authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Research Qi, Xiao-Ping Peng, Jian-Zhong Yang, Xiao-Wei Cao, Zhi-Lie Yu, Xiu-Hua Fang, Xu-Dong Zhang, Da-Hong Zhao, Jian-Qiang The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis |
title | The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis |
title_full | The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis |
title_fullStr | The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis |
title_full_unstemmed | The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis |
title_short | The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis |
title_sort | ret c611y mutation causes men 2a and associated cutaneous lichen amyloidosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176283/ https://www.ncbi.nlm.nih.gov/pubmed/30300539 http://dx.doi.org/10.1530/EC-18-0220 |
work_keys_str_mv | AT qixiaoping theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT pengjianzhong theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT yangxiaowei theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT caozhilie theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT yuxiuhua theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT fangxudong theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT zhangdahong theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT zhaojianqiang theretc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT qixiaoping retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT pengjianzhong retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT yangxiaowei retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT caozhilie retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT yuxiuhua retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT fangxudong retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT zhangdahong retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis AT zhaojianqiang retc611ymutationcausesmen2aandassociatedcutaneouslichenamyloidosis |